SCHEMBL1315554

SCHEMBL1315554

CC(C)(C)OC(=O)Nc1cccc(-c2ccc(C(=O)OC(C)(C)C)c([N+](=O)[O-])c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.50
ABCB1 P08183 1/20 0.45
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
MMP13 P45452 1/20 0.43
FBP1 P09467 1/20 0.41
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
HDAC1 Q13547 5/20 0.40
HDAC4 P56524 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12121153 0.91 CYP17A1 (0.50) CYP17A1ABCB1MMP1MMP2MMP9
SCHEMBL27989386 0.88 CYP17A1 (0.44) CYP17A1ABCB1MMP1MMP2MMP9
SCHEMBL27828461 0.86 CYP17A1 (0.46) CYP17A1ABCB1MMP1MMP2MMP9
SCHEMBL4221601 0.83 ABCB1 (0.52) ABCB1MEN1MAPTKMT2AALOX5
SCHEMBL12117498 0.82 ABCB1 (0.42) ABCB1FBP1MEN1POLBKMT2A
SCHEMBL2274516 0.81 ABCB1 (0.41) ABCB1MAPT
SCHEMBL1316782 0.81 TRPV1 (0.43) ABCB1MEN1MAPTHTTKMT2A
SCHEMBL4415459 0.81 ALDH1A1 (0.48) MEN1MAPTHTTKMT2ASMN1; SMN2
SCHEMBL13632920 0.81 CYP17A1 (0.47) CYP17A1MMP1MMP2MMP9MMP8
SCHEMBL4210431 0.79 ALOX5 (0.43) ABCB1FBP1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 CYP17A1 698/4885ABCB1 4395/4885MMP1 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.